本页面由Tiger Trade Technology Pte. Ltd.提供服务

BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD

0.3950
-0.0652-14.17%
成交量:21.11万
成交额:8.85万
市值:40.65万
市盈率:-0.07
高:0.4700
开:0.4700
低:0.3861
收:0.4602
52周最高:52.05
52周最低:0.3861
股本:102.91万
流通股本:94.35万
量比:2.01
换手率:22.37%
股息:- -
股息率:- -
每股收益(TTM):-5.6940
每股收益(LYR):-78.3088
净资产收益率:-42.00%
总资产收益率:-40.11%
市净率:0.03
市盈率(LYR):-0.01

数据加载中...

2026/09/24

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/30

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2026/07/15

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/27

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/12/18

SEC问询函

Form CORRESP - Correspondence
2025/12/18

SEC问询函

Form CORRESP - Correspondence
2025/12/11

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/12/08

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/11/18

SEC问询函

Form CORRESP - Correspondence
2025/11/17

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2025/09/30

SEC问询函

Form CORRESP - Correspondence
2025/08/20

SEC问询函

Form CORRESP - Correspondence
2025/04/11

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/24

SEC问询函

Form CORRESP - Correspondence
2025/01/17

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/11/20

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]